1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1620
  5. Art Unit 1622
  6. Examiner Javanmard

Examiner Javanmard Sahar

1622-JAVANMARD-SAHAR

Employment Information

Art Unit:1622 — Drug, bio-affecting and body treating compositions
Group:1620 — Biomedicinal Chemistry
Classes: 514 — Drug, bio-affecting and body treating compositions
424 — Drug, bio-affecting and body treating compositions
548 — Organic compounds -- part of the class 532-570 series
504 — Plant protecting and regulating compositions
436 — Chemistry: analytical and immunological testing
540 — Organic compounds -- part of the class 532-570 series
Phone:(571) 270-3280
Email:sahar.javanmard@uspto.gov
Location:VA 22314
Title:Pat Examnr Gen Chem
Service:19 years
Grade:GS-14

Grant Rate and Difficulty Ranking

64
3-Year Grant rate: 68% over 381 cases
Difficulty: Harder
Difficulty Percentile: 64th

With Examiner Javanmard, you have a 68% chance of getting an issued patent by 3 years after the first office action. Examiner Javanmard is a harder examiner and in the 64th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Javanmard, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1622

Examiner Javanmard's grant rate is lower than that of Art Unit 1622 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Javanmard 1.3
Art Unit 1622 1.1

Interview Benefit

Grant Rate without Interview

Examiner Javanmard has granted 220 of 330 cases without any applicant-requested interviews for a grant rate of 67%.

Grant Rate with Interview

Examiner Javanmard has granted 38 of 51 cases with at least one applicant-requested interview for a grant rate of 75%.

Interview Benefit

With Examiner Javanmard, conducting an interview increases your chance of getting a patent granted by 12%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
19210898 Pharmaceutical Dosage Forms And Methods Of Use Rejection information available with a Premium Stats subscription. See our pricing. Patented View
18320159 A19-144, A2-73 And Certain Anticholinesterase Inhibitor Compositions And Method For Anti-Seizure Therapy Patented View
17844715 Methods For Treating Inflammatory Skin Conditions Patented View
17922767 Method For Treating Central Nervous System Disorders Using Dopamine D3 Partial Agonists Patented View
18005841 Use Of Cannabidiol In The Treatment Of Seizures Associated With Rare Epilepsy Syndromes Related To Genetic Abnormalities Abandoned View
19182010 Compounds And Combinations Thereof For Treating Neurological And Psychiatric Conditions Patented View
17795609 Therapeutic Agent For Myalgic Encephalomyelitis/chronic Fatigue Syndrome Patented View
16523568 Method For Treating Epilepsy Patented View
18793674 Enthesis Healing Patented View
18064676 Compositions And Methods For Treating Acne Vulgaris Abandoned View
17788615 Use Of Losartan For The Treatment Of Fibrotic Diseases, In Particular Epidermolysis Bullosa Patented View
17914572 Compositions For Treatment Of Aged Diseases Abandoned View
18009161 Methods And Compositions For Treating Mild Traumatic Brain Injury, Post-Traumatic Stress Disorder And Mild Traumatic Brain Injury With Post Traumatic Stress Disorder Abandoned View
18030853 Phenyl-3,4-Dihydroisoquinolin-2(1h)-Yl-Ethan-1-One Derivatives As Dopamine D1receptor Positive Allosteric Modulators Patented View
17620670 Antibacterial And Antiparasitic Quinoxaline-2,3-Diamine Derivatives Patented View
18178336 Methods For Killing Antibiotic Tolerant Bacteria Patented View
17788813 Use Of A Benzodiazepine Derivative And Method Of Treatment Of Traumatic Brain Injury Abandoned View
18004658 1-[1-(4-Benzyloxy-3,5-Difluoro-Benzoyl)-4-Fluoro-Pyrrolidine-2-Carbonyl]-Pyrrolidine-2-Carbonitrile Patented View
17830532 3-(5-Chloro-2-Oxobenzo[D]oxazol-3(2h)-Yl) Propanoic Acid Derivatives As Kmo Inhibitors Patented View
18964259 Use Of Chidamide In Preparing Drug For Treating Renal Fibrosis Patented View
18170235 Use Of Cannabinoids In The Treatment Of Epilepsy Abandoned View
18152616 Ffa1 (Gpr40) As A Therapeutic Target For Neural Angiogenesis Diseases Or Disorders Abandoned View
17967383 Pesticidal Compositions And Related Methods Patented View
17782534 Use Of Fgfr Inhibitors For Treatment Of Idiopathic Short Stature Patented View
18776438 Method Of Using Iloprost For Treating Frostbite Patented View
18180398 Mitofusin Activators And Methods Of Use Thereof Patented View
17979670 Treatment Of Disease With Esters Of Selective Rxr Agonists Abandoned View
17979661 Treatment Of Disease With Esters Of Selective Rxr Agonists Abandoned View
18101499 Treatment Of A Hematologic Malignancy With 2-(4-Chlorophenyl)-N-((2-(2,6- Dioxopiperidin-3-Yl)-1-Oxoisoindolin-5-Yl)methyl)-2,2-Difluoroacetamide Abandoned View
17778802 Prophylactic Skin Treatment For Radiation Therapy Patented View
17777734 Cannabidiol-Type Cannabinoid Compound Patented View
17667323 Novel D3 Dopamine Receptor Agonists To Treat Dyskinesia In Parkinson's Disease Abandoned View
17777681 Cannabidiol-Type Cannabinoid Compound Patented View
17776222 Oleic Acid Derivatives As Treatments For Friedreich Ataxia And Inhibitors Of Ferroptosis Patented View
19018731 Pharmaceutical Compositions And Methods For Treating Psychiatric Disorders Patented View
17984833 Alpha-Amino Esters Of Hydroxypropylthiazolidine Carboxamide Derivative And Salt Form, Crystal Polymorph Thereof Abandoned View
17851395 Hydrogen Containing Composition And Methods Of Using The Same Abandoned View
17216756 Selective Estrogen Receptor Modulator For Treatment Of Pancreatic Cancer Abandoned View
17777677 Cannabidiol-Type Cannabinoid Compound Patented View
18375745 Pkc-Activating Compounds For The Treatment Of Neurodegenerative Diseases Abandoned View
17818083 Composition For Treating Hair Loss Or Promoting Hair Growth, Comprising Piperonylic Acid Patented View
17875679 Pharmaceutical Composition For Reducing Local Fat And Uses Thereof Patented View
18083502 Composition For Promoting Normal Urinary Function Patented View
17832058 Citrulline For Treatment Of Sickle Cell Crisis Patented View
17099224 Enthesis Healing Patented View
17666324 More Potent And Less Toxic Formulations Of Epinephrine And Methods Of Medical Use Patented View
18764507 Sulforaphane-Cysteine For Wound Healing In Diabetic Subjects Patented View
16095282 Compounds And Methods For Treating Neurological And Cardiovascular Conditions Patented View
16163108 Prophylactic Or Therapeutic Agent For Neuropathic Pain Associated With Guillain-Barre Syndrome Abandoned View
17568477 Triple Combination Formulation For Treatment Of Chronic Pain Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.